Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PfizerfiledCriticalPfizer
Priority to CU20100105ApriorityCriticalpatent/CU20100105A7/en
Publication of CU20100105A7publicationCriticalpatent/CU20100105A7/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La invención se refiere a los compuestos de la fórmula (I) ESPACIO PARA LA FÓRMULA procedimientos para su preparación, su uso como inhibidores de 5-lipoxigenasa y composiciones farmacéuticas que los contienen.The invention relates to the compounds of the formula (I) SPACE FOR FORMULA procedures for their preparation, their use as 5-lipoxygenase inhibitors and pharmaceutical compositions containing them.
CU20100105A2010-05-262010-05-26
PIRAZOL DERIVATIVES AS 5-LO INHIBITORS
CU20100105A7
(en)
NEW DERIVATIVES OF 6-TRIALZOLOPIRIDACINA-SULFANIL BENZOTIAZOL AND BENCIMIDAZOL, ITS PREPARATION PROCEDURE, ITS APPLICATION AS MEDICATIONS, PHARMACEUTICAL COMPOSITIONS AND NEW MAIN USE AS MET INHIBITORS.